Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2008
10/09/2008US20080248329 Light sources comprising organic light emmiters between electrodes, used in displaying, electrophotography, recording, exposure, signs or optical communications; brightness; efficiency; durability; iridium complex
10/09/2008US20080247992 N-Carboxyalkyl-1-cyclohexyl-2-substituted phenylbenzimidazole-5-carboxamides (2-[(1-cyclohexyl-2-{2-fluoro-4-[3-(aminocarbonyl)-6-(4-chlorophenyl)benzyloxy]-phenyl}-1H-benzimidazole-5-carbonyl)-amino]-3-(5-hydroxy-1H-indol-3-yl)-propionic acid); Flavivirus family infections such as hepatitus C
10/09/2008CA2682727A1 Indoledione derivative
10/09/2008CA2682649A1 Imidazolidine carboxamide derivatives as p2x7 modulators
10/09/2008CA2682535A1 Acetone solvate of phthaloyl amlodipine
10/09/2008CA2682473A1 Novel pyrrolinone derivative and pharmaceutical composition comprising the same
10/09/2008CA2681979A1 Indole derivatives having cpla2 inhibiting activity and applications and production methods of the same
10/09/2008CA2681733A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/09/2008CA2679728A1 Sub-type selective azabicycloalkane derivatives
10/08/2008EP1978023A1 Pyridazines as fungicides
10/08/2008EP1978019A1 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
10/08/2008EP1977751A1 Use of crystalline (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole for manufacturing pharmaceutical compositions
10/08/2008EP1977749A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
10/08/2008EP1976850A1 Novel lanthanide ligands and complexes, and use thereof as contrast agents
10/08/2008EP1976849A2 Compounds for the treatment of inflammatory disorders
10/08/2008EP1976848A2 Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists
10/08/2008EP1976847A2 Pyrimidinyl aryl urea derivatives being fgf inhibitors
10/08/2008EP1976841A1 Heterocyclic amide derivatives as calcium channel blockers
10/08/2008EP1976836A2 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases
10/08/2008EP1976834A2 Heterocycle substituted ketone derivatives as histone deacetylase (hdac) inhibitors
10/08/2008EP1976829A2 N-(6-membered aromatic ring)-amido anti-viral compounds
10/08/2008EP1976515A2 Combination therapy with parp inhibitors
10/08/2008EP1976385A2 Anthranilamide derivatives and their use for the control of insects and acari
10/08/2008EP1922135A4 Hindered cyclic polyamines and their salts for acid gas scrubbing process
10/08/2008EP1881830B1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility
10/08/2008EP1633348B1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
10/08/2008EP1606283B1 P38 inhibitors and methods of use thereof
10/08/2008EP1539693B9 Cannabinoid receptor agonists
10/08/2008EP1478628B1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
10/08/2008EP1389100B1 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
10/08/2008EP1379246B1 Nociceptin analogs
10/08/2008EP1064298B1 Inhibitors of caspases
10/08/2008EP1043995B9 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
10/08/2008CN101282964A Oxopyridyl quinoline amides as NK3 receptor modulators
10/08/2008CN101282963A Pyrazole derivatives as therapeutic agents
10/08/2008CN101282962A Compounds for the treatment of inflammatory disorders
10/08/2008CN101282961A Alkylpyridyl quinolines as NK3 receptor modulators
10/08/2008CN101282960A RAF inhibitor compounds and methods
10/08/2008CN101282948A Phosphatidylinositol 3-kinase inhibitors and methods of their use
10/08/2008CN101282943A Pyrimidine amide compounds as PGDS inhibitors
10/08/2008CN101282942A Imidazole derivatives for the treatment of anxiety and related diseases
10/08/2008CN101282941A Imidazole compounds for the treatment of neurological disorders
10/08/2008CN101282938A Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/08/2008CN101282932A Carboxyamine compounds and their use in the treatment of HDAC dependent diseases
10/08/2008CN101282931A Tanaka Hiroaki
10/08/2008CN101279971A 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same
10/08/2008CN100424082C 4-(piperidyl- and pyrrolidyl-alkyl-ureido) -quinolines as urotensin ii receptor antagonists
10/08/2008CN100424079C Bis-sulfonamides
10/08/2008CN100424078C Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
10/08/2008CN100423721C Thrombopoietin mimetics
10/07/2008US7432379 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process
10/07/2008US7432378 For example, 2-{2-Chloro-4-[3-(4-methyl-piperazin-1-yl)-propoxy]-phenyl}-4,5-dimethyl-1H-benzoimidazole; use in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions
10/07/2008US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432288 Pyrrole-2,5-dione derivatives as Liver X receptor modulators
10/07/2008US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
10/07/2008US7432282 3-{4-[(5-bromopyridin-3-ylmethyl)amino]butyl}-1H-indole-5-carbonitrile; neuroleptics and/or antihypertensives; bioavailability; absorbability
10/07/2008US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/07/2008US7432275 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
10/07/2008US7432271 Atherosclerosis; anticholesterol agents; cardiovascular disorders; stroke; thrombosis; hypotensive agents; restenosis; antidiabetic agents; antiarthritic agents; anticancer agnets; inflammatory bowel disorders
10/07/2008US7432270 N-aroyl cyclic amines
10/07/2008US7432269 Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents
10/07/2008US7432268 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
10/07/2008US7432266 Phosphodiesterase 4 inhibitors
10/07/2008US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain
10/07/2008US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
10/07/2008CA2435946C Piperidine derivatives as neurokinin 1 antagonists
10/07/2008CA2433772C Pyrimidine matrix metalloproteinase inhibitors
10/07/2008CA2392971C 2,4-diaminopyrimidine compounds useful as immunosuppressants
10/07/2008CA2362831C Thioamide derivatives
10/02/2008WO2008118849A2 Hiv-1 protease inhibitors
10/02/2008WO2008118790A1 Dihydroindazole compounds useful in treating iron disorders
10/02/2008WO2008118455A1 δ3- SUBSTITUTED QUINOLINE OR QUINOXALINE DERIVATIVES AND THEIR USE AS PHOSPHATIDYLINOSITOL 3-KINASE ( PI3K) INHIBITORS
10/02/2008WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
10/02/2008WO2008117861A1 Intraocular pressure lowering agents containing phenylenediamine derivatives as the active ingredient
10/02/2008WO2008117826A1 Compound for organic electroluminescent device and organic electroluminescent device
10/02/2008WO2008117773A1 Process for production of asymmetric tetrasubstituted quinolonecarboxylic acids and intermediates for the production
10/02/2008WO2008117303A1 Indole derivatives and their metal conjugates and uses thereof
10/02/2008WO2008117298A1 A novel method of preparation of imatinib
10/02/2008WO2008117079A1 Antimicrobial compounds based upon 4-aminoquinoline
10/02/2008WO2008117050A1 Pyrazolyl-amino-substituted pyrazines and their use for the treatment of cancer
10/02/2008WO2008116881A1 Substituted pyrrolidine amides, the production thereof, and the use thereof as medications
10/02/2008WO2008116831A1 Quinoline compounds suitable for treating didorders that respond to modulation of the serotonin 5-ht6 receptor
10/02/2008WO2008116671A1 2,3,4,9-tetrahydro-1h-carbazoles
10/02/2008WO2008116620A1 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
10/02/2008WO2008099076A3 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
10/02/2008WO2008097640A3 Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
10/02/2008WO2008094507A3 Novel fusion compounds
10/02/2008WO2008084223A3 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
10/02/2008WO2008075172A3 Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
10/02/2008WO2008075068A3 Acylaminopyrazoles as fgfr inhibitors
10/02/2008WO2008067120A3 (s)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use
10/02/2008WO2008059259A3 Anticancer compounds with a benzo ( 1, 2, 4 ) triazin-3yl-amine core
10/02/2008WO2008053194A3 Pyridine carboxamides as 11-beta-hsd1 inhibitors
10/02/2008WO2007139968A3 Triazole compounds that modulate hsp90 activity
10/02/2008WO2007111864A3 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
10/02/2008WO2006131338A3 Crystalline solvate of omeprazole sodium
10/02/2008US20080242866 Synthesis of anthranilamides
10/02/2008US20080242865 Processes for the preparation of hydroxylamines
10/02/2008US20080242716 Ion Channel Modulators
1 ... 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 ... 1080